BioMS Medical Announces First quarter 20...(poration) Interim Consolidated Statem...)

Date:5/11/2009

poration) Interim Consolidated Statements of Operations and Comprehensive Loss (Unaudited) ------------------------------------------------------------------------- (expressed in thousands of Canadian dollars and shares, except per share amounts) Cumulative from inception to Three-month period ended March 31, March 31, ------------- ------------------------- 2009 2009 2008 $ $ $ Revenue earned from collaboration partner 65,618 13,057 12,769 Less: Research and development expenses (163,594) (11,509) (13,143) ------------- ------------------------- (97,976) 1,548 (374) General and administrative expenses (45,453) (2,848) (8,695) Amortization of licensing costs (12,123) (368) (368) Amortization of property and equipment (560) (43) (12) ------------- ------------------------- Loss from operations (156,112) (1,711) (9,449) Other income Investment income 8,949 170 729 Foreign exchange gain 5,722 142 2,035 ------------- ------------- ---------- 14,671 312 2,764 -
'/>"/>

SOURCE BioMS Medical Corp. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9
Related biology technology :

1. BioMS Medical to present at Alberta Economic Forum in Geneva
2. BioMS Medical to present at BioFinance 2009
3. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
5. BioMS Medical Announces 2008 Year End Results
6. BioMS Medical warrant extension
7. BioMS Medical to present at BIO CEO and Investor Conference
8. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
9. BioMS Medical recognized at Scrip Awards 2008
10. BioMS Medical Announces Third Quarter 2008 Results
11. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference